EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Glioneuronal Tumour With Neurocytic Differentiation (GNTN): a Molecularly Defined Tumour Type Formerly Referred to as Extraventricular Neurocytoma

Alice Métais, Myriam Edjlali, Farah Sassi, Guillaume Chotard, Emmanuelle Uro-Coste, Benoit Lhermitte, Romain Appay, Giuseppe Pinto, Christian Thomas iD, Luca Bertero iD, Miriam Ratliff, Sandro M Krieg iD und 4 weitere

Neuropathology and Applied Neurobiology · 2026-06 · 52 (3)

DOI: 10.1111/nan.70080 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neuropathology and Applied Neurobiology, online erschienen am 21.05.2026. Verfasst von Alice Métais und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neuropathology, GHU Paris - Psychiatry and Neuroscience, Sainte-Anne Hospital, Paris, France. Hauptthemen laut MEDLINE: Neurocytoma, Brain Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Else Kröner-Fresenius-Stiftung, Dr. Rolf M. Schwiete Stiftung.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tumours historically classified as extraventricular neurocytoma (EVN), initially in comparison with central neurocytoma, are defined by location and morphology; however, emerging molecular data demonstrate that this term is outdated. We report 14 previously unpublished tumours with a robust EVN DNA methylation profile, independent of original histopathologic diagnosis or anatomic location. Integrated molecular analyses identified FGFR1 alterations, particularly FGFR1::TACC1 fusions, as the predominant molecular driver of this tumour class. A smaller number of tumours harboured FGFR1 hotspot mutations (p.N546K and p.K656E). Among these, two cases additionally showed NF1 variants, and one tumour carried a PIK3CA mutation (p.H1047L). In addition, a single case exhibited an NTRK2 fusion. Histologically, tumours exhibited neurocytic differentiation with neuropil islands and a minor glial component, while immunohistochemistry showed frequent OLIG2 expression, contrasting with the typical immunophenotype of central neurocytoma. Notably, tumours with an EVN DNA methylation profile were identified in both extraventricular and intraventricular locations, demonstrating that anatomy‐based definitions are inadequate for this tumour type. Clinical follow‐up (median 33.2 months) showed predominantly lower grade behaviour, with occasional recurrence. Collectively, these findings support the view that tumours previously labelled as EVN do not represent a direct counterpart of central neurocytoma but instead constitute a molecularly and epigenetically distinct glioneuronal tumour type. We propose the designation glioneuronal tumour with neurocytic differentiation (GNTN) to reflect its biological identity and to align the terminology with contemporary molecular neuropathology, and recommend DNA methylation profiling as an essential diagnostic criterion.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeurocytomaBrain NeoplasmsHumansDNA MethylationFemaleReceptor, Fibroblast Growth Factor, Type 1MaleClass I Phosphatidylinositol 3-KinasesMutationNeurofibromin 1AdultMembrane GlycoproteinsCell Adhesion MoleculesReceptor, trkBFetal ProteinsMicrotubule-Associated ProteinsNuclear Proteins

Stichwörter der Autor:innen

FGFR1::TACC1DNA methylationNTRK fusionsextraventricular neurocytomaglioneuronal tumour with neurocytic differentiation (GNTN)supratentorial tumours

Substanzen

Receptor, Fibroblast Growth Factor, Type 1FGFR1 protein, humanTACC1 protein, humanClass I Phosphatidylinositol 3-KinasesPIK3CA protein, humanNeurofibromin 1Membrane GlycoproteinsCell Adhesion Moleculestropomyosin-related kinase-B, humanReceptor, trkB

Autor:innen und Institutionen

  • Department of Neuropathology, GHU Paris - Psychiatry and Neuroscience, Sainte-Anne Hospital, Paris, France.
  • Translational Research in Neuroscience Lab, Institut Imagine, Université Paris Cité, Paris, France.
  • Multimodal Biomedical Imaging Laboratory (BioMaps), Frédéric Joliot Hospital Department, Paris-Saclay University, CEA, CNRS, Inserm, Orsay, France.
  • Department of Radiology, APHP, Paris, France.
  • Department of Pathology, University Hospital of Bordeaux, Pellegrin Hospital, Bordeaux, France.
  • Department of Pathology, Toulouse University Hospital, Toulouse, France.

ORCID-Profile: Christian Thomas, Luca Bertero, Sandro M Krieg, Felix Sahm, Philipp Sievers

Förderung

  • Else Kröner-Fresenius-Stiftung
  • Dr. Rolf M. Schwiete Stiftung

Zitieren

APA

Métais, A., Edjlali, M., Sassi, F., Chotard, G., Uro-Coste, E., Lhermitte, B., Appay, R., Pinto, G., Thomas, C., Bertero, L., Ratliff, M., Krieg, S. M., von Deimling, A., Sahm, F., Varlet, P., & Sievers, P. (2026). Glioneuronal Tumour With Neurocytic Differentiation (GNTN): a Molecularly Defined Tumour Type Formerly Referred to as Extraventricular Neurocytoma. Neuropathology and Applied Neurobiology, 52(3). https://doi.org/10.1111/nan.70080

Vancouver

Métais A, Edjlali M, Sassi F, Chotard G, Uro-Coste E, Lhermitte B, et al. Glioneuronal Tumour With Neurocytic Differentiation (GNTN): a Molecularly Defined Tumour Type Formerly Referred to as Extraventricular Neurocytoma. Neuropathology and Applied Neurobiology. 2026;52(3). doi:10.1111/nan.70080

BibTeX
@article{Mtais2026,
  author = {Métais, Alice and Edjlali, Myriam and Sassi, Farah and Chotard, Guillaume and Uro-Coste, Emmanuelle and Lhermitte, Benoit and Appay, Romain and Pinto, Giuseppe and Thomas, Christian and Bertero, Luca and Ratliff, Miriam and Krieg, Sandro M and von Deimling, Andreas and Sahm, Felix and Varlet, Pascale and Sievers, Philipp},
  title = {Glioneuronal Tumour With Neurocytic Differentiation (GNTN): a Molecularly Defined Tumour Type Formerly Referred to as Extraventricular Neurocytoma},
  journal = {Neuropathology and Applied Neurobiology},
  year = {2026},
  volume = {52},
  number = {3},
  doi = {10.1111/nan.70080}
}
Kostenlos starten →